This company listing is no longer active
CS Medica (CSMED) Stock Overview
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
CSMED Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
CS Medica A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 1.01 |
| 52 Week High | DKK 17.99 |
| 52 Week Low | DKK 0.48 |
| Beta | -0.47 |
| 1 Month Change | -84.02% |
| 3 Month Change | -88.07% |
| 1 Year Change | -85.74% |
| 3 Year Change | -89.67% |
| 5 Year Change | n/a |
| Change since IPO | -90.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| CSMED | SE Pharmaceuticals | SE Market | |
|---|---|---|---|
| 7D | 64.6% | -3.4% | -1.5% |
| 1Y | -85.7% | -24.2% | 10.5% |
Return vs Industry: CSMED underperformed the Swedish Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: CSMED underperformed the Swedish Market which returned 7.8% over the past year.
Price Volatility
| CSMED volatility | |
|---|---|
| CSMED Average Weekly Movement | 32.3% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.6% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: CSMED's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: CSMED's weekly volatility has increased from 24% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 9 | Lone Henriksen | www.cs-medica.com |
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name.
CS Medica A/S Fundamentals Summary
| CSMED fundamental statistics | |
|---|---|
| Market cap | DKK 9.07m |
| Earnings (TTM) | -DKK 9.65m |
| Revenue (TTM) | DKK 8.46m |
Is CSMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSMED income statement (TTM) | |
|---|---|
| Revenue | DKK 8.46m |
| Cost of Revenue | DKK 5.25m |
| Gross Profit | DKK 3.21m |
| Other Expenses | DKK 12.86m |
| Earnings | -DKK 9.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 17, 2025
| Earnings per share (EPS) | -0.70 |
| Gross Margin | 37.92% |
| Net Profit Margin | -114.06% |
| Debt/Equity Ratio | 219.3% |
How did CSMED perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/13 10:12 |
| End of Day Share Price | 2025/01/09 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CS Medica A/S is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christian Sandherr | NuWays AG |